Cargando…
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single‐centre cohort
Osteonecrosis (ON) is a well‐known sequela of paediatric acute lymphoblastic leukaemia (ALL) treatment. Incidence differs substantially among studies and the clinical significance of radiological findings is not fully established. We analysed 256 consecutive patients with ALL treated in our Institut...
Autores principales: | Brivio, Erica, Cossio, Andrea, Borra, Davide, Silvestri, Daniela, Prunotto, Giulia, Colombini, Antonella, Verna, Marta, Rizzari, Carmelo, Biondi, Andrea, Conter, Valentino, Valsecchi, Maria Grazia, Balduzzi, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323502/ https://www.ncbi.nlm.nih.gov/pubmed/35362095 http://dx.doi.org/10.1111/bjh.18147 |
Ejemplares similares
-
Blinatumomab as bridging therapy in paediatric B‐cell acute lymphoblastic leukaemia complicated by invasive fungal disease
por: Yeoh, Daniel K., et al.
Publicado: (2022) -
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
por: Balduzzi, Adriana, et al.
Publicado: (2020) -
Distinctive genotypes in infants with T‐cell acute lymphoblastic leukaemia
por: Mansur, Marcela B., et al.
Publicado: (2015) -
Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response
por: Sassen, Sebastiaan D. T., et al.
Publicado: (2021) -
Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands
por: Schwartz, Emily R, et al.
Publicado: (2023)